Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Antonelli

Showing results (601-610 of 858) with videos related to

Pageof 86
Sort By:
Seminars in Oncology|May 24, 2022
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumabRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
European Urology Focus|August 2, 2022
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial NephrectomyGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Journal of Robotic Surgery|November 7, 2024
Development and validation of a novel comorbidity score specific for prostate cancer patients treated with robotic platform and its implication on DaVinci single-port systemDonato Cannoletta, Elio Mazzone, Paolo Dell'Oglio, et al.
World Journal of Urology|January 9, 2022
Simultaneous robotic partial nephrectomy for bilateral renal massesFabrizio Gallo, Simone Sforza, Lorenzo Luciani, et al.
BJU International|August 30, 2011
Prognostic factors in a large multi-institutional series of papillary renal cell carcinomaAlessandro Zucchi, Giacomo Novara, Elisabetta Costantini, et al.
International Urology and Nephrology|October 22, 2021
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancerAntonio Benito Porcaro, Sebastian Gallina, Alberto Bianchi, et al.
World Journal of Urology|October 12, 2022
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
World Journal of Urology|August 1, 2012
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinomaPaolo Gontero, Maxine Sun, Alessandro Antonelli, et al.
The Journal of Urology|November 28, 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell CarcinomaGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Oncology Reports|March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Pageof 86

Showing results (601-610 of 858) with videos related to

Sort By:
Pageof 86
Seminars in Oncology|May 24, 2022
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumabRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
European Urology Focus|August 2, 2022
Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial NephrectomyGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Journal of Robotic Surgery|November 7, 2024
Development and validation of a novel comorbidity score specific for prostate cancer patients treated with robotic platform and its implication on DaVinci single-port systemDonato Cannoletta, Elio Mazzone, Paolo Dell'Oglio, et al.
World Journal of Urology|January 9, 2022
Simultaneous robotic partial nephrectomy for bilateral renal massesFabrizio Gallo, Simone Sforza, Lorenzo Luciani, et al.
BJU International|August 30, 2011
Prognostic factors in a large multi-institutional series of papillary renal cell carcinomaAlessandro Zucchi, Giacomo Novara, Elisabetta Costantini, et al.
International Urology and Nephrology|October 22, 2021
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancerAntonio Benito Porcaro, Sebastian Gallina, Alberto Bianchi, et al.
World Journal of Urology|October 12, 2022
Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicityGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
World Journal of Urology|August 1, 2012
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinomaPaolo Gontero, Maxine Sun, Alessandro Antonelli, et al.
The Journal of Urology|November 28, 2022
Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell CarcinomaGabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, et al.
Oncology Reports|March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivoSilvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Pageof 86